FDA approves Merilog (insulin-aspart-szjj) as the first rapid-acting insulin biosimilar to Novolog for glycemic control in adult and pediatric diabetes patients, expanding treatment accessibility.
SGLT-2 inhibitors and GLP-1 receptor agonists were associated with a reduced risk of moderate or severe COPD exacerbations compared with DPP-4 inhibitors in adults with type 2 diabetes.
SARS-CoV-2 infection is associated with accelerated coronary plaque progression and a nearly threefold higher risk of target lesion failure, according to a new study.
Pseudochilblains were linked to exaggerated IFN-1 production by plasmacytoid dendritic cells, according to new findings on COVID-19-related skin diseases.